de Witte T

A randomized phase II study of low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in myelodysplastic syndromes (MDS) with a high risk of developing leukemia. EORTC Leukemia Cooperative Group.

Gerhartz Hh, R. E. Marcus, Alain Delmer et al. · PubMed · 1994 · 56 citations

Medicine, Hematology, Oncology +16

Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.

De Pauw Be, Donnelly Jp, de Witte T et al. · PubMed · 1990 · 47 citations

Pharmacy, Clinical Pharmacy, Pharmacotherapy +16

Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent.

Petra Muus, Peter Donnelly, A Schattenberg et al. · PubMed · 1993 · 22 citations

Medicine, Hematology, Pharmacology +14

Irradiated donor buffy coat following T cell-depleted bone marrow transplants.

Aloïs Gratwohl, André Tichelli, A. Würsch et al. · PubMed · 1988 · 19 citations

Medicine, Hematology, Immunology +14

No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized study.

Aloïs Gratwohl, J. Hermans, von Biezen A et al. · PubMed · 1992 · 17 citations

Medicine, Hematology, Oncology +11